BioCentury
ARTICLE | Clinical News

Mydicar: Phase II started

September 1, 2014 7:00 AM UTC

Celladon began a double-blind, placebo-controlled, U.K. Phase II trial to evaluate Mydicar in about 24 HF patients with an LVAD. The British Heart Foundation is partially funding the trial and Imperial College London is sponsoring it. ...